Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Tea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Lung Neoplasms 6 Colonic Neoplasms 4 Pancreatic Neoplasms 3 Pain, Postoperative 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Male Urogenital Diseases 2 Leiomyoma 2 Inflammatory Bowel Diseases 2 Inflammation 2 Diverticulitis 2 Carcinoma, Non-Small-Cell Lung 2 Agnosia 2 Abdominal Cancer 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Shoulder Pain 1 Psychological Well-Being 1 Postoperative Complications 1 Post-thoracotomy Pain Syndrome 1 Pleural Diseases 1 Neoplasms 1 Mouth Neoplasms 1 Motor Activity 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡